It has been reported for CML that SOCS2 is overexpressed in advanced tumor stages and that SOCS2 expression is dependent on the Bcr-Abl mutation [26]. Here, SOCS2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.